天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 27398-39-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 27398-39-6
Chemical Structure| 27398-39-6
Structure of 27398-39-6 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 27398-39-6 ]

Related Doc. of [ 27398-39-6 ]

Alternatived Products of [ 27398-39-6 ]
Product Citations

Product Citations      Expand+

Gregory R. Armel ; James T. Brosnan ; Nilda R. Burgos , et al. DOI:

Abstract: Numerous similarities exist between the structure–activity relationships of pharmaceutical drugs and pesticides, creating the potential for finding new crop management tools with novel mechanisms of action. Analogues of pyrazinamide and its active metabolite pyrazinoic acid were evaluated on a variety of monocot and dicot species to assess their potential as commercial herbicides. Six analogues, applied postemergence at 3 kg ai/ha, controlled yellow nutsedge (Cyperus esculentus) ≥ the commercial standards bentazon or imazethapyr. The compound 5-fluoropyrazine-2-carboxylic acid provided between 71 and 95% control of barnyardgrass (Echinochloa crus-galli) and yellow nutsedge with only modest injury (8–25%) to soybean (Glycine max). A similar compound containing a bromine atom in the 5-position controlled yellow nutsedge greater than bentazon and affected soybean, sweet corn (Zea mays convar. saccharata var. rugosa), and rice (Oryza sativa) in a similar fashion to bentazon as well. The herbicidal sites of action targeted by these analogues of pyrazinamide and pyrazinoic acid are unknown, but it is hypothesized that they may be disrupting targets in the biosynthesis pathways of nicotinamide adenine dinucleotide (NAD) and/or ethylene.

Keywords: herbicide ; rice ; pyrazinamide ; pharmaceutical ; prodrug ; soybean ; sweet corn

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Yuan, Gengyang ; Dhaynaut, Maeva ; Lan, Yu , et al. DOI: PubMed ID:

Abstract: Metabotropic glutamate receptor 2 (mGluR2) is a therapeutic target for several neuropsychiatric disorders. An mGluR2 function in etiology could be unveiled by positron emission tomography (PET). In this regard, 5-(2-fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide ([11C]13, [11C]mG2N001), a potent negative allosteric modulator (NAM), was developed to support this endeavor. [11C]13 was synthesized via the O-[11C]methylation of phenol 24 with a high molar activity of 212 ± 76 GBq/μmol (n = 5) and excellent radiochemical purity (>99%). PET imaging of [11C]13 in rats demonstrated its superior brain heterogeneity and reduced accumulation with pretreatment of mGluR2 NAMs, VU6001966 (9) and MNI-137 (26), the extent of which revealed a time-dependent drug effect of the blocking agents. In a nonhuman primate, [11C]13 selectively accumulated in mGluR2-rich regions and resulted in high-contrast brain images. Therefore, [11C]13 is a potential candidate for translational PET imaging of the mGluR2 function.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Hegde, Pooja V. ; Aragaw, Wassihun W. ; Cole, Malcolm S. , et al. DOI: PubMed ID:

Abstract: Tuberculosis (TB) remains a leading cause of infectious disease-related mortality and morbidity. Pyrazinamide (PZA) is a critical component of the first-line TB treatment regimen because of its sterilizing activity against non-replicating Mycobacterium tuberculosis (Mtb), but its mechanism of action has remained enigmatic. PZA is a prodrug converted by pyrazinamidase encoded by pncA within Mtb to the active moiety, pyrazinoic acid (POA) and PZA resistance is caused by loss-of-function mutations to pyrazinamidase. We have recently shown that POA induces targeted protein degradation of the enzyme PanD, a crucial component of the CoA biosynthetic pathway essential in Mtb. Based on the newly identified mechanism of action of POA, along with the crystal structure of PanD bound to POA, we designed several POA analogs using structure for interpretation to improve potency and overcome PZA resistance. We prepared and tested ring and carboxylic acid bioisosteres as well as 3, 5, 6 substitutions on the ring to study the structure activity relationships of the POA scaffold. All the analogs were evaluated for their whole cell antimycobacterial activity, and a few representative mols. were evaluated for their binding affinity, towards PanD, through isothermal titration calorimetry. We report that analogs with ring and carboxylic acid bioisosteres did not significantly enhance the antimicrobial activity, whereas the alkylamino-group substitutions at the 3 and 5 position of POA were found to be up to 5 to 10-fold more potent than POA. Further development and mechanistic anal. of these analogs may lead to a next generation POA analog for treating TB.

Keywords: Tuberculosis ; Pyrazinoic acid ; pyrazinamide

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Product Details of [ 27398-39-6 ]

CAS No. :27398-39-6 MDL No. :MFCD01318438
Formula : C5H3ClN2O2 Boiling Point : No data available
Linear Structure Formula :- InChI Key :PMRPVXLESNMKLG-UHFFFAOYSA-N
M.W : 158.54 Pubchem ID :1501900
Synonyms :

Calculated chemistry of [ 27398-39-6 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 34.0
TPSA : 63.08 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.6
Log Po/w (XLOGP3) : 0.6
Log Po/w (WLOGP) : 0.83
Log Po/w (MLOGP) : -0.61
Log Po/w (SILICOS-IT) : 0.97
Consensus Log Po/w : 0.48

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.58
Solubility : 4.18 mg/ml ; 0.0264 mol/l
Class : Very soluble
Log S (Ali) : -1.5
Solubility : 5.03 mg/ml ; 0.0317 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.63
Solubility : 3.72 mg/ml ; 0.0234 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.74

Safety of [ 27398-39-6 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 27398-39-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 27398-39-6 ]

[ 27398-39-6 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 14508-49-7 ]
  • [ 124-38-9 ]
  • [ 27398-39-6 ]
  • 2
  • [ 20737-42-2 ]
  • [ 27398-39-6 ]
  • 3
  • [ 15454-54-3 ]
  • [ 27398-39-6 ]
  • [ 122509-59-5 ]
  • 4
  • [ 27398-39-6 ]
  • [ 90361-99-2 ]
YieldReaction ConditionsOperation in experiment
With thionyl chloride; N,N-dimethyl-formamide; In toluene; at 95℃; for 1h; 3-Cl-POA (1.0 g, 6.3 mmol) was dispersed in dry toluene (approx. 50 mL) with thionyl chloride (1.4 mL, 18.9 mmol, 3 equiv.) and a catalytic amount (1-2 drops) of N,N-dimethylformamide (DMF). The reaction mixture in round bottomed flask was stirred and heated in an oil bath under a condenser at 95 °C for approximately 1 h. Solvents were evaporated in vacuo and the residue was azeotroped with dry toluene (3 × 20 mL) to remove the unreacted SOCl2 to yield crude acyl chloride [43] as brown solid, which was used without further purification.
With thionyl chloride; N,N-dimethyl-formamide; In toluene; at 95℃; for 1h; General procedure: A total of 0.3 g of 3-Cl-POA (1.9 mmol) was dispersed in dry toluene with thionyl chloride(0.4 mL, 5.7 mmol, 3 equiv.) and 1?2 drops of N,N-dimethylformamide (DMF) as a catalyst. Thereaction mixture was stirred and heated in a round bottom flask in an oil bath under a condenser,at 95°C for 1 h. The solvent was evaporated in vacuo and the residue was azeotroped with dry toluene(3 20 mL). The acyl chloride was used for the following step, without purification. The whole amount of the 3-chloropyrazine-2-carbonyl chloride prepared in the previousstep was dissolved in dry acetone. An appropriate benzylamine (5.7 mmol, 3 equiv., with respect to the starting acid), along with triethylamine (1.9 mmol, 1 equiv.), were added to thereaction mixture and stirred at laboratory temperature overnight. The progress of the reactionwas checked by TLC in system hexane/ethyl acetate (1:1 or 2:1). The reaction mixture wasadsorbed to silica by removing the solvents in vacuo and the product was purified by flashchromatography using gradient elution with ethyl acetate in hexane. For compounds 1?3,corresponding N-benzyl-3-(benzylamino)pyrazine-2-carboxamides 1a?3a were formed simultaneouslyin a molar ratio of approximately 2:3, with an excess of 1a?3a. Rf in hexane/ethyl acetate 1:1 mobilephase: 1a?0.85, 1?0.49, 2a?0.84, 2?0.51, 3a?0.71, and 3?0.40. After flash-chromatography,compounds 2, 2a, 3, 3a, 4, 8, and 13 were recrystallized from EtOH/H2O.
With oxalyl dichloride; In dichloromethane; N,N-dimethyl-formamide; for 5h;Reflux; 1.59 g (10 mmol) of <strong>[27398-39-6]3-chloropyrazine-2-carboxylic acid</strong> was dissolved in 20 mL of dichloromethane solvent, 2.54 g (20 mmol) of oxalyl chloride, 2 drops of DMF,After stirring at reflux for 5 h, the solvent and excess oxalyl chloride were evaporated under reduced pressure.Obtained a purplish red oil; it was dissolved in 20 mL of dichloromethane.Add 0.92g (5mmol)Ethyl 5-(methylaminomethyl)-1H-imidazole-4-carboxylate and1.52 g (15 mmol) of triethylamine,After stirring at room temperature until the reaction was completed, it was poured into 50 mL of saturated sodium bicarbonate solution, and extracted with dichloromethane (20 mL × 4).After filtration, the solvent was evaporated under reduced pressure to give ethyl 5-((3-chloro-N-methylpyrazine-2-carboxamido)methyl)-1H-imidazole-4-carboxylate.Ethyl 5-((3-chloro-N-methylpyrazine-2-carboxamido)methyl)-1H-imidazole-4-carboxylate was dissolved in 20 mL of acetonitrile.Add 3.26 g (10 mmol) of cesium carbonate,The mixture was stirred under reflux until the reaction was completed, and the solvent was evaporated under reduced pressure.It was dissolved in 20 mL of dichloromethane.Wash with distilled water (30 mL × 2), dry over anhydrous sodium sulfate,After filtration, the solvent was evaporated under reduced pressure.Column chromatography (EtOAc, 1percent Et3N),A white solid was obtained in a two step yield of 55percent.
  • 6
  • [ 27398-39-6 ]
  • [ 128011-39-2 ]
  • 7
  • [ 27398-39-6 ]
  • [ 128011-41-6 ]
  • 8
  • [ 27398-39-6 ]
  • [ 128011-43-8 ]
  • 9
  • [ 367-25-9 ]
  • [ 27398-39-6 ]
  • [ 931105-81-6 ]
YieldReaction ConditionsOperation in experiment
53% Example 41; 3-(4-(2-Aminopyridin-4-yloxy)-3-fluorophenylamino)-N-(2,4-difluorophenyl)pyrazine-2-carboxamide, bis(trifluoroacetic acid) salt; A) 3-Chloro-N-(2,4-difluorophenyl)pyrazine-2-carboxamide; To a mixture of <strong>[27398-39-6]3-chloropyrazine-2-carboxylic acid</strong> (Tyger Scientific, 500 mg, 3.15 mmol) in methylene chloride (30 mL) and DMF (0.1 mL) was added oxalyl chloride (593 mg, 4.7 mmol). After stirring 30 min the reaction mixture was concentrated in vacuo. The residue was taken up in acetonitrile (12 mL) and was treated with triethylamine (920 mg, 9.1 mmol) and 2,4-difluoroaniline (430 mg, 3.3 mmol) and stirred 30 min. The reaction mixture was partitioned between ethyl acetate and brine. The organic layer was washed with brine, dried over anhydrous MgSO4, and then concentrated in vacuo. The resulting solid was recrystallized (ethyl acetate/hexanes) to give the amide (455 mg, 53percent) as a solid. MS(ESI+) m/z 270 (M+H)+.
  • 10
  • [ 77390-81-9 ]
  • [ 27398-39-6 ]
  • [ 1060687-81-1 ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; Example 10 (4-Oxo-3,4-dihydro-pteridin-2-ylmethyl)-carbamic acid benzyl ester10.1 {2-[(3-Chloro-pyrazine-2-carbonyl)-amino]-2-imino-ethyl}-carbamic acid benzyl ester; Under an atmosphere of nitrogen, <strong>[27398-39-6]3-chloro-2-pyrazinecarboxylic acid</strong> (76 mg), TBTU (168 mg), and diisopropylethylamine (310 mg) were added to a solution of carbamimidoylmethyl-carbamic acid benzyl ester [77390-81-9] (99 mg) in DMF (6 ml). The reaction mixture was stirred for 2 h at ambient temperature, diluted with dichloromethane and washed with water. The organic layer was dried (Na2SO4), filtered, and the solvent was evaporated. The obtained, crude title compound (220 mg) was used without further purification in the next step.
  • 11
  • [ 958358-70-8 ]
  • [ 27398-39-6 ]
  • [ 1060687-63-9 ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 4.5h; 2.3 3-Chloro-pyrazine-2-carboxylic acid{2-[2-(2,5-difluoro-phenyl)-ethoxy]-1-imino-ethyl}-amide; 2-[2-(2,5-Difluoro-phenyl)-ethoxy]-acetamidine hydrochloride (158 mg, 0.631 mmol) was dissolved in DMF (3 ml) and <strong>[27398-39-6]3-chloro-2-pyrazine-carboxylic acid</strong> (100 mg, 0.631 mmol), TBTU (213 mg, 0.662 mmol) and DIPEA (565 mul, 3.15 mmol) were added. The reaction mixture was stirred at ambient temperature for 4.5 h. Then water was added and the mixture was extracted three times with CH2Cl2. The combined organic extracts were washed with water and brine, dried (Na2SO4) and evaporated. The crude title compound (195 mg, brown gum) was used for the next reaction step without further purification. MS: m/e=355.2 [M+H+].
  • 12
  • [ 958361-36-9 ]
  • [ 27398-39-6 ]
  • [ 1060687-79-7 ]
YieldReaction ConditionsOperation in experiment
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 2h; 9.3 3-Chloro-pyrazine-2-carboxylic acid[1-imino-2-(2-naphthalen-2-yl-ethoxy)-ethyl]-amide; Under an atmosphere of nitrogen, <strong>[27398-39-6]3-chloro-2-pyrazinecarboxylic acid</strong> (Tyger, 250 mg), TBTU (532 mg), and diisopropylethylamine (1.34 ml) were added to a solution of 2-(2-naphthalen-2-yl-ethoxy)-acetamidine hydrochloride (417 mg) in DMF (5 ml). The reaction mixture was stirred for 2 h at r.t., diluted with dichloromethane and washed with water. The organic layer was dried (Na2SO4), filtered, and the solvent was evaporated. The obtained, crude title compound (567 mg) was used without further purification in the next step.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 27398-39-6 ]

Chlorides

Chemical Structure| 27825-21-4

[ 27825-21-4 ]

Methyl 3-chloropyrazine-2-carboxylate

Similarity: 0.90

Chemical Structure| 655247-45-3

[ 655247-45-3 ]

Ethyl 3-chloropyrazine-2-carboxylate

Similarity: 0.88

Chemical Structure| 356783-15-8

[ 356783-15-8 ]

3,6-Dichloropyrazine-2-carboxylic acid

Similarity: 0.88

Chemical Structure| 312736-49-5

[ 312736-49-5 ]

3,5-Dichloropyrazine-2-carboxylic acid

Similarity: 0.86

Chemical Structure| 121246-96-6

[ 121246-96-6 ]

3-Chloropyrazine-2-carbaldehyde

Similarity: 0.80

Carboxylic Acids

Chemical Structure| 356783-15-8

[ 356783-15-8 ]

3,6-Dichloropyrazine-2-carboxylic acid

Similarity: 0.88

Chemical Structure| 312736-49-5

[ 312736-49-5 ]

3,5-Dichloropyrazine-2-carboxylic acid

Similarity: 0.86

Chemical Structure| 98-97-5

[ 98-97-5 ]

Pyrazine-2-carboxylic acid

Similarity: 0.71

Chemical Structure| 20254-76-6

[ 20254-76-6 ]

3-Chloroquinoxaline-2-carboxylic acid

Similarity: 0.70

Chemical Structure| 41110-28-5

[ 41110-28-5 ]

3-Methylpyrazine-2-carboxylic acid

Similarity: 0.68

Related Parent Nucleus of
[ 27398-39-6 ]

Pyrazines

Chemical Structure| 27825-21-4

[ 27825-21-4 ]

Methyl 3-chloropyrazine-2-carboxylate

Similarity: 0.90

Chemical Structure| 655247-45-3

[ 655247-45-3 ]

Ethyl 3-chloropyrazine-2-carboxylate

Similarity: 0.88

Chemical Structure| 356783-15-8

[ 356783-15-8 ]

3,6-Dichloropyrazine-2-carboxylic acid

Similarity: 0.88

Chemical Structure| 312736-49-5

[ 312736-49-5 ]

3,5-Dichloropyrazine-2-carboxylic acid

Similarity: 0.86

Chemical Structure| 121246-96-6

[ 121246-96-6 ]

3-Chloropyrazine-2-carbaldehyde

Similarity: 0.80

; ;